Bulletin
Investor Alert

AgeX Therapeutics Inc.

ASE: AGE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 23, 2021, 7:34 p.m.

AGE
/zigman2/quotes/208090696/composite

$

1.60

Change

+0.10 +6.67%

Volume

Volume 7,369

Quotes are delayed by 20 min

/zigman2/quotes/208090696/composite

Previous close

$ 1.53

$ 1.50

Change

-0.03 -1.96%

Day low

Day high

$1.40

$1.54

Open

52 week low

52 week high

$0.75

$3.93

Open

Insider Actions for AgeX Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/11/2021 Michael D. West
Chief Executive Officer; Director
1,081   Derivative/Non-derivative trans. at $1.53 per share. 1,653
06/11/2021 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
03/11/2021 Michael D. West
Chief Executive Officer; Director
1,284   Derivative/Non-derivative trans. at $2.03 per share. 2,606
03/11/2021 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
12/11/2020 Michael D. West
Chief Executive Officer; Director
1,081   Derivative/Non-derivative trans. at $1.69 per share. 1,826
12/11/2020 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
09/11/2020 Michael D. West
Chief Executive Officer; Director
1,081   Derivative/Non-derivative trans. at $0.81 per share. 875
09/11/2020 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
06/11/2020 Michael D. West
Chief Executive Officer; Director
1,081   Derivative/Non-derivative trans. at $0.8 per share. 864
06/11/2020 Michael D. West
Chief Executive Officer; Director
3,125   Derivative/Non-derivative trans. at $0 per share. 0
03/11/2020 Michael D. West
Chief Executive Officer; Director
5,085   Derivative/Non-derivative trans. at $0.88 per share. 4,474
03/11/2020 Michael D. West
Chief Executive Officer; Director
12,500   Derivative/Non-derivative trans. at $0 per share. 0
08/13/2019 Juvenescence Ltd.
19,000   Acquisition at $0 per share. 0
12/10/2018 Michael D. West
Chief Executive Officer; Director
4,000   Acquisition at $3.86 per share. 15,440

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
1 Sales
3,125
1,081
Last 6 months
2 Purchases
2 Sales
6,250
2,365
Last 12 months
4 Purchases
4 Sales
12,500
4,527

Officers and Executives

Dr. Michael D. West
President, Chief Executive Officer & Director
Dr. Nafees N. Malik
Chief Operating Officer
Ms. Andrea E. Park
Chief Financial Officer
Dr. Hal Sternberg
Vice President-Research
Dr. Ivan Labat
Chief Information Officer
Ms. Judith Segall
Secretary
Dr. Gregory H. Bailey
Chairman
Dr. Michael H. May
Independent Director
Dr. Annalisa Mary Jenkins
Independent Director
Link to MarketWatch's Slice.